Literature DB >> 2786028

IL-6 is an intermediate in IL-1-induced thymocyte proliferation.

M Helle1, L Boeije, L A Aarden.   

Abstract

Both IL-1 and IL-6 have been shown to be comitogenic for lectin-stimulated thymocytes. Thymocytes cultured in the presence of IL-1 produce IL-6 themselves. This IL-6 production is caused by a cell population with low buoyant density. After removal of these cells, IL-6 or IL-2 are still co-mitogenic for thymocytes whereas IL-1 is not. Addition of IL-1 to such thymocytes renders them about 100-fold more sensitive to IL-6. At all conditions proliferation is inhibitable with antibodies to IL-2 and to the IL-2R. Our experiments show that IL-1-driven proliferation of thymocytes is dependent on endogenous IL-6 production and that in the classical thymocyte assay IL-1 has a dual role: it induces IL-6 production and it greatly increases the sensitivity for IL-6.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786028

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Effects of recombinant human interleukin-6 alone and in combination with recombinant interleukin-1 alpha and tumor necrosis factor alpha on antibacterial resistance in mice.

Authors:  C J Czuprynski; M Haak-Frendscho; N Maroushek; J F Brown
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

3.  Production and modulation of interleukin 6 synthesis by synoviocytes derived from patients with arthritic disease.

Authors:  J T Rosenbaum; R Cugnini; D C Tara; S Hefeneider; J C Ansel
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

Review 4.  IL-1 acts on T cells to enhance the magnitude of in vivo immune responses.

Authors:  S Z Ben-Sasson; Stephane Caucheteux; Michelle Crank; Jane Hu-Li; William E Paul
Journal:  Cytokine       Date:  2011-08-16       Impact factor: 3.861

5.  In vitro interleukin-1 (IL-1) production in thymic hyperplasia and thymoma from patients with myasthenia gravis.

Authors:  C Aime; S Cohen-Kaminsky; S Berrih-Aknin
Journal:  J Clin Immunol       Date:  1991-09       Impact factor: 8.317

6.  Characterization of unique lymphoid cells derived from murine spleen which constitutively produce interleukin-6.

Authors:  H C O'Neill; K Ni
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

7.  Effect of respiratory syncytial virus-antibody complexes on cytokine (IL-8, IL-6, TNF-alpha) release and respiratory burst in human granulocytes.

Authors:  R Arnold; F Werner; B Humbert; H Werchau; W König
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

8.  Human hepatoma cells expressing MHC antigens display accessory cell function: dependence on LFA-1/ICAM-1 interaction.

Authors:  M Paroli; G Carloni; A Franco; G De Petrillo; E Alfani; A Perrone; V Barnaba
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

9.  Identification of dendritic cells as a major source of interleukin-6 in draining lymph nodes following skin sensitization of mice.

Authors:  J C Hope; M Cumberbatch; I Fielding; R J Dearman; I Kimber; S J Hopkins
Journal:  Immunology       Date:  1995-11       Impact factor: 7.397

10.  Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus.

Authors:  R Arnold; B Humbert; H Werchau; H Gallati; W König
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.